Torrent Pharmaceuticals Share Price Live blog for 20 Oct 2023
Torrent Pharmaceuticals stock price went up today, 20 Oct 2023, by 0.91 %. The stock closed at 1918.45 per share. The stock is currently trading at 1935.85 per share. Investors should monitor Torrent Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post Quarterly Financial Result Conference Call with Investors / Analyst TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2023 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Monday, 23-Oct-23, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-23. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation regarding Change in Senior Management Personnel of the Company TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Intimation of the Closure of Trading Window TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
Torrent Pharma in talks with Apollo to borrow up to $1 bn for Cipla bid: Report
Torrent is hoping to secure roughly $3 billion to $4 billion in financing for the bid for its much bigger rival, the report said TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates